Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Dose-Escalating Efficacy and Safety Study of Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy

NCT00080132 is registered in ClinicalTrials.gov with Medical Research Laboratories International as lead sponsor.

NCT NCT00080132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00080132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Dose-Escalating Efficacy and Safety Study of Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy
Lead sponsor
Medical Research Laboratories International
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2004
Completion date
April 30, 2005
Enrollment
50
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hypertriglyceridemia